Botanical species · safety record
Ruellia tuberosa
The EFSA Compendium of Botanicals holds 5 constituent measurements and 1 adverse-effect record for Ruellia tuberosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Ruellia tuberosa L.
Regulatory presence
No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.
What the records describe
Constituents measured
- Alkaloids2
- Saponins2
- Tannins1
Plant parts
- Roots and other underground parts2
- Aerial part of plants1
- Flower1
- Live plants1
- Shoot1
Preparations
- Solvent extraction6
Effect types
- Digestive1
Target tissues
- Urogenital: urinary bladder1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| Tannins | Live plants | Solvent extraction | — | Phytochemical screening | Resolve DOI |
| Alkaloids | Shoot | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Alkaloids | Roots and other underground parts | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Saponins | Flower | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
| Saponins | Roots and other underground parts | Solvent extraction | — | Phytochemical screening | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Digestive | Urogenital: urinary bladder | Aerial part of plants | Solvent extraction | — | In vitro | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Sinha, S. K. P., Dogra, J. V. V. A survey of the plants of Bhagalpur and Santhal Pargana for saponin, flavonoids and alkaloids. International Journal of Crude Drug Research, 1985, p. 77-86.
- Ratna Wulan, Dyah., Priyo Utomo, Edi., Mahdi, Chanif. Antidiabetic Activity of Ruellia tuberosa L., Role of alpha-Amylase Inhibitor: In Silico, In Vitro, and In Vivo Approaches. . Biochemistry research international, 2015, vol. 2015, p. 349261. DOI
- Arirudran, B., Saraswathy, A., Krishnamurthy, V. Pharmacognostic and preliminary phytochemical studies on Ruellia tuberosa L. (whole plant). Pharmacognosy Journal, 2011, vol. 3, no. 22, p. 29-34. DOI
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.